Human very low density lipoprotein receptor,VLDLR ELISA Kit

Contact us for 48 wells and bulk quote

Introducing the Human Very Low Density Lipoprotein Receptor, VLDLR ELISA Kit, a cutting-edge solution designed to facilitate accurate and efficient measurement of VLDLR levels in human samples. This state-of-the-art kit is meticulously crafted to cater to the needs of researchers and clinicians alike, providing a reliable and comprehensive tool for investigating the role of VLDLR in various physiological and pathological processes.

The Human VLDLR ELISA Kit boasts a highly sensitive and specific assay system, enabling precise quantification of VLDLR concentrations within a wide dynamic range. Leveraging advanced immunological principles, this kit ensures minimal cross-reactivity and interference, guaranteeing the utmost accuracy in VLDLR detection.

With its user-friendly protocol, the Human VLDLR ELISA Kit streamlines experimental procedures, allowing for seamless integration into laboratory workflows. The kit includes all necessary components, meticulously optimized to ensure optimal performance and reproducibility. From sample preparation to data analysis, this comprehensive solution empowers researchers to obtain reliable and insightful results with ease.

Furthermore, the Human VLDLR ELISA Kit exhibits exceptional versatility, accommodating a diverse range of sample types, including serum, plasma, and cell culture supernatants. This adaptability enables researchers to explore VLDLR dynamics across various biological contexts, facilitating a deeper understanding of its implications in health and disease.

In summary, the Human Very Low Density Lipoprotein Receptor, VLDLR ELISA Kit represents a pinnacle of scientific innovation, offering a robust and efficient means of quantifying VLDLR levels in human samples. With its unparalleled sensitivity, specificity, and user-friendly design, this kit empowers researchers and clinicians to unravel the intricate mechanisms underlying VLDLR biology, paving the way for novel therapeutic interventions and improved patient outcomes.